These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 11062079)

  • 1. [Nuclear oncology 2000: the end of individualized professionalism].
    Carrio I
    Rev Esp Med Nucl; 2000 Jun; 19(3):179-81. PubMed ID: 11062079
    [No Abstract]   [Full Text] [Related]  

  • 2. The industry and the profession: friends or foes?
    Jeans J; Vermeeren P
    Eur J Nucl Med; 1998 Nov; 25(11):1469-71. PubMed ID: 9882183
    [No Abstract]   [Full Text] [Related]  

  • 3. Multidisciplinary care and emerging technologies: optimizing patient care or truce in a turf battle?
    Rose CM
    J Am Coll Radiol; 2004 Sep; 1(9):624-5. PubMed ID: 17411668
    [No Abstract]   [Full Text] [Related]  

  • 4. [GMP production.Shaping the future].
    Wester HJ
    Nuklearmedizin; 2012; 51(1):N1-4. PubMed ID: 22448395
    [No Abstract]   [Full Text] [Related]  

  • 5. The future role of the gastroenterologist in digestive oncology: an international perspective.
    Winawer SJ; Pasricha PJ; Schmiegel W; Sinicrope FA; Sung J; Seufferlein T; Kassem AM; Malekzadeh R; Kurtz RC; Classen M; Tytgat GN
    Gastroenterology; 2011 Oct; 141(4):e13-21. PubMed ID: 21871854
    [No Abstract]   [Full Text] [Related]  

  • 6. The profession and the industry: friends and foes.
    Ell PJ
    Eur J Nucl Med; 1998 Nov; 25(11):1472-4. PubMed ID: 9882184
    [No Abstract]   [Full Text] [Related]  

  • 7. Advancing molecular imaging from the laboratory to everyday practice.
    VanBrocklin HF
    J Nucl Med; 2008 Dec; 49(12):22N-23N. PubMed ID: 19038993
    [No Abstract]   [Full Text] [Related]  

  • 8. Unparalleled contribution of 18F-FDG PET to medicine over 3 decades.
    Basu S; Alavi A
    J Nucl Med; 2008 Oct; 49(10):17N-21N, 37N. PubMed ID: 18832112
    [No Abstract]   [Full Text] [Related]  

  • 9. Future of nuclear medicine, part 2: assessment of the U.S. diagnostic radio-pharmaceuticals market (2001-2020).
    J Nucl Med; 1998 Mar; 39(3):20N, 22N-25N. PubMed ID: 9529277
    [No Abstract]   [Full Text] [Related]  

  • 10. Nuclear medicine and oncology.
    Lind P; Gallowitsch HJ
    Wien Med Wochenschr; 2012 Oct; 162(19-20):405-6. PubMed ID: 23099624
    [No Abstract]   [Full Text] [Related]  

  • 11. The future of nuclear medicine: a perspective from Europe.
    Ell PJ
    J Nucl Med; 1993 Jan; 34(1):169-70. PubMed ID: 8117340
    [No Abstract]   [Full Text] [Related]  

  • 12. SNM clinical trials network validates 100th scanner.
    Graham M; Conti P; Hoffman J
    J Nucl Med; 2011 Jun; 52(6):25N. PubMed ID: 21622892
    [No Abstract]   [Full Text] [Related]  

  • 13. Radiopharmacology: recent developments in the field of radiopharmaceuticals.
    Cutler CS
    Q J Nucl Med Mol Imaging; 2015 Sep; 59(3):239-40. PubMed ID: 26404758
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulatory issues are primary focus for nuclear medicine groups.
    Nichols D
    J Nucl Med; 1997 Feb; 38(2):17N. PubMed ID: 9025728
    [No Abstract]   [Full Text] [Related]  

  • 15. Professionalism and cancer care.
    Abeloff MD; Reynolds PP
    Bull Am Coll Surg; 1994 May; 79(5):12-7. PubMed ID: 10134112
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of in vivo imaging of the central nervous system for developing novel drugs.
    Rueger MA; Kracht LW; Hilker R; Thiel A; Sobesky J; Winkeler A; Thomas AV; Heneka MT; Graf R; Herholz K; Heiss WD; Jacobs AH
    Q J Nucl Med Mol Imaging; 2007 Jun; 51(2):164-81. PubMed ID: 17420717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personalized medicine in oncology, the potential role of nuclear medicine imaging.
    Van de Wiele C; Mees G
    Curr Pharm Des; 2014; 20(14):2231-3. PubMed ID: 24025097
    [No Abstract]   [Full Text] [Related]  

  • 18. Future of nuclear medicine, part 3: assessment of the U.S. therapeutic radiopharmaceuticals market (2001-2020).
    J Nucl Med; 1998 Jul; 39(7):14N, 17N-18N, 20N-22N, 25N, 27N. PubMed ID: 9669377
    [No Abstract]   [Full Text] [Related]  

  • 19. Medical imaging in the nineties: new directions for nuclear medicine.
    Maynard CD
    J Nucl Med; 1993 Jan; 34(1):157-64. PubMed ID: 8418260
    [No Abstract]   [Full Text] [Related]  

  • 20. Future of nuclear medicine, part 1: marketing research forecasts.
    J Nucl Med; 1998 Feb; 39(2):27N-30N. PubMed ID: 9476920
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.